DJIA 17,070.50 91.37 0.54%
NASDAQ 4,532.57 6.09 0.13%
S&P 500 1,994.18 7.67 0.39%
market minute promo

Amicus Therapeutics, Inc. (NASDAQ: FOLD)

5.42 -0.08 (-1.45%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

FOLD $5.42 -1.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.31
Previous Close $5.50
Daily Range $5.16 - $5.57
52-Week Range $1.77 - $5.99
Market Cap $426.6M
P/E Ratio -5.73
Dividend (Yield) $0.00 (0.0%)
Volume 4,877,671
Average Daily Volume 2,356,520
Current FY EPS -$0.89

Sector

Healthcare

Industry

Drugs

Amicus Therapeutics, Inc. (FOLD) Description

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. Website: http://www.amicusrx.com/

News & Commentary Rss Feed

Why Amicus Therapeutics, Inc. Stock Is Soaring Today

Amicus Therapeutics' shares are soaring today. Here's why.

Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape

Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape

Perilous Reversal Stock: Amicus Therapeutics (FOLD)

Sector Update: Health Care Stocks Rebound Late; Amicus Therapeutics Gives Up Much of Wednesday Advan

Sector Update: Health Care Stocks Rebound Late; Amicus Therapeutics Gives Up Much of Wednesday Advance

Sector Update: Health Care

Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcrip

Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript)

Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today

Stocks Hitting 52-Week Highs

Morning Market Movers

See More FOLD News...

FOLD's Top Competitors

FOLD $5.42 (-1.45%)
Current stock: FOLD
AMGN $132.53 (-0.11%)
Current stock: AMGN
GILD $102.12 (1.32%)
Current stock: GILD
BIIB $338.23 (-1.27%)
Current stock: BIIB